Drug Makers Concerned about Cost-Effective Assessments Used for NHI Price Cuts: Survey

Drug makers expect cost-effective assessments (CEAs) to be used to cut NHI drug prices, a survey by Nomura Research Institute has revealed. With growing pressure to reduce the drug expenditure, drug makers seem to be concerned that the government will...read more